Projects and Grants per year
Grants and Contracts Details
Description
• To determine whether IGIV, 10% treatment either at a dose of 400 mglkg
body weight (BW)/2 weeks or 200 mg/ kg BW/2 weeks for 9 months results
in a significantly slower rate of decline of dementia symptoms in subjects with
mild-to-moderate AD as compared to placebo, as measured by ADAS-Cog
and the ADCS-CGIC.)
| Status | Finished |
|---|---|
| Effective start/end date | 11/15/08 → 6/30/13 |
Funding
- University of California San Diego Health: $426,015.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 2 Finished
-
Study of the Safety and Effectiveness of Immune Globulin Intravenous (IGIV) for the Treatment of Mild to Moderate Alzheimer Disease
Jicha, G. (PI), Schmitt, F. (CoI), Stiles, N. (CoI) & Cooper, G. (Former CoI)
University of California San Diego Health
7/1/09 → 6/30/12
Project: Research project
-
Study of the Safety and Effectiveness of Immune Globulin Intravenous (IGIV) for the Treatment of Mild to Moderate Alzheimer Disease
Jicha, G. (PI), Schmitt, F. (CoI), Stiles, N. (CoI) & Cooper, G. (Former CoI)
University of California San Diego Health
11/15/08 → 6/30/12
Project: Research project